CompoAtlas

LifeVantage Liquid Collagen

Natural health product licensed in Canada

Other names
LifeVantage Collagen
Licence holder
Lifevantage
NPN or DIN-HM
80123893
Status
Active licence
Licence date
14 April 2023
Revision date
11 February 2024
Form
Liquide
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Lycopène tout trans

Source : Solanum lycopersicum - Chair (fruit)

15 mgNot calculated
Vaccinium angustifolium

Source : Vaccinium angustifolium - Fruit

50 mgNot calculated

Non-medicinal ingredients

Sucrose, Poudre de Spinacia Oleracea (Epinard), Eau, Maltodextrine, Amidon alimentaire, modifié, Carbonate de dipotassium, Extrait de fruit de Malpighia Glabra (Acérola), Concentré de jus de Canneberge, Acide 2-méthylbutyrique, Diméthylhydroxy furanone, dl-alpha tocophérol, Acide citrique, Acétoïne, Cétone de framboise, Ascorbate de sodium, Propylène glycol, Concentré de jus de pommes, Acétyl propionyle, Sorbate de potassium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years50 mL1 day

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of/Provides antioxidants. Helps to reduce joint pain associated with osteoarthritis. Source of (the) essential amino acid(s) (histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, valine) for the maintenance of good health (and involved in protein synthesis). Source of (the) non-essential amino acid(s) (alanine, arginine, aspartic acid, glutamic acid, glycine, proline, serine, tyrosine) involved in protein synthesis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80123893

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line